The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two ...

Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...

Noninvasive monitoring methods, such as enterography and ultrasound, are becoming increasingly recognized as essential tools ...

An international team led by researchers at the University of Toronto has found a compound in ginger, called furanodienone ...

The intestinal epithelium is a highly dynamic barrier that regulates digestion, absorption, immune responses, and ...

The mystery of why people with Inflammatory Bowel Disease (IBD) have a four times higher risk of getting life threatening ...

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...

Inflammatory bowel disease (IBD) affects between 2.4 and 3.1 million people across the United States, according to the ...

Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...

Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...